Assessment of EGFR gene mutations in circulating free DNA in monitoring of response to EGFR tyrosine kinase inhibitors in patients with lung adenocarcinoma.
Nicoś M, Wojas-Krawczyk K, Krawczyk P, Chmielewska I, Wojcik-Superczyńska M, Reszka K, Kieszko R, Góra-Florek A, Dudek M, Świniuch D, Papiewski W, Całka P, Ciesielka M, Ramlau R, Milanowski J.
Nicoś M, et al. Among authors: chmielewska i.
Arch Med Sci. 2019 Nov 3;16(6):1496-1500. doi: 10.5114/aoms.2019.89217. eCollection 2020.
Arch Med Sci. 2019.
PMID: 33224359
Free PMC article.
No abstract available.